611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
I've Already Had COVID-19, Do I Need the Vaccine?What Will COVID-19 Look Like Years From Now?First Computer Model of Entire COVID Virus Will Aid ResearchStopping Common Heart Meds Could Be Risky for Kidney PatientsU.S. COVID Vaccine Rollout Nears 1 Million Doses Per DayJohnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialLockdowns' Benefits for Air Quality Weren't as Big as Thought: StudyPeople's 'Microbiomes' Might Influence COVID-19 Severity: StudyNew Insights Into How COVID-19 Damages the BrainCollege Campuses Are COVID 'Superspreaders,' Study FindsStuck at Home, Suffering With COVID? Experts Offer Guidance on CareCOVID Daily Death Toll Sets New U.S. Record, Soars Past 4,400AHA News: Registries Could Offer Insight Into COVID-19's Impact on College Athletes' HeartsResearch Reveals Why COVID Pneumonia Is More DeadlyPandemic Is Tied to Big Rise in U.S. Heart DeathsCommon Diabetes Meds Tied to Serious COVID-19 ComplicationPlant-Based Diet Brings Better 'Microbiome,' Healthier LifeAnswering Your Qs on the New COVID VaccinesEven Mild Cases of COVID Can Leave 'Long-Haul' Illness, Study ShowsCommon Blood Pressure Meds Won't Up Risks for COVID Patients: StudySix Months Later, Most Wuhan COVID Survivors Still Have Health IssuesHealth Officials Work to Speed Up U.S. COVID Vaccine RolloutAllergists' Group Offers Guidelines on COVID-19 VaccinesFacebook Posts Big Drivers in Vaccine Resistance, Study FindsBlack Patients at Higher Risk When Type 1 Diabetes and COVID CombineBiden Says He Will Release All Vaccine Doses After Taking Office'Pandemic Fatigue' Setting in? Here's How to Stay Safe and StrongCould High Pollen Levels Trigger Pelvic Pain?Record Number of COVID Cases, Deaths Reported in U.S.COVID Survivors' Plasma Might Prevent Worsening Illness in Older Patients: StudyAHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Certain Antibiotics Linked With Upped Risk for Deadly Aortic AneurysmsDeath Risk Nearly Doubles When COVID Strikes People With Heart FailureMore Infectious COVID Variant Likely Widespread in the U.S., Experts SayRed Cross Issues Call for More Blood Plasma to Treat COVID PatientsPediatricians' Group Says School Is Priority, With Proper Safety MeasuresMoves, Evictions Often Trigger Harmful Breaks in Health Care: StudyAllergic Reactions to COVID Vaccines Are Rare, Resolved on Site: CDCSurvey Shows Mental Woes Spiked in U.S. Pandemic's First MonthsYour 'To-Do' List as You Await a COVID VaccineSome Americans Can't Access Telemedicine, Study ShowsU.S. COVID Hospitalizations Reach Record High as California Hospitals Run Out of OxygenVaccine Rollout Could Have Americans Back to Normalcy by Summer, Expert SaysCould Umbilical Cord Stem Cells Be a Lifesaver Against Severe COVID-19?Kids With Congenital Heart Disease Face Higher Odds of Mental Health IssuesAlmost 47 Million Americans Already Infected With Coronavirus by Nov. 15: StudyAllergists Offer Reassurance on COVID Vaccines' SafetyBrain May Age Faster After Spinal Cord InjuryOn Waitlist for Liver Transplants, Women Die More Often Than MenGlobal Warming May Be Triggering Toxic Algae Blooms Along U.S. West Coast
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Americans With Asthma Get First Updated Guidelines in Over a Decade

HealthDay News
by By Steven Reinberg HealthDay Reporter
Updated: Dec 3rd 2020

new article illustration

THURSDAY, Dec. 3, 2020 (HealthDay News) -- The U.S. National Institutes of Health has updated guidelines for treating asthma.

The update is the first in 13 years and takes into account new medications and other advances in asthma care. It focuses on treatment tailored for different age groups and severity of disease.

But better asthma care won't come from new guidelines alone, according to the American Lung Association's chief medical officer.

"Patients need to realize that open communication with their physician is the key to controlling asthma," said Dr. Albert Rizzo, who was not involved in creating the guidelines.

Depending on the severity of disease, there are many options for treating asthma. There are ways of increasing -- or decreasing -- therapy if needed, but Rizzo said doctors need to be aware of new approaches to treatment and be attuned to how their patients are feeling and coping with the condition.

Asthma causes the airways to narrow, making breathing difficult. An estimated 25 million Americans suffer from asthma, including nearly 6 million children, according to the U.S. Centers for Disease Control and Prevention.

Without treatment, asthma can limit activities and cause flare-ups that can result in hospitalization or even death.

Dr. Michelle Cloutier is head of the National Asthma Education Prevention Program Expert Panel Working Group, which developed the new guidelines. At a briefing on Wednesday she told reporters that the guidelines focus on six areas:

  • Using inhaled corticosteroids and short-acting bronchodilators, as needed, for recurrent wheezing or persistent asthma. This is a major change in asthma treatment, according to Cloutier. "This treatment approach not only results in improved asthma outcomes, such as the reduction in the number of asthma exacerbations, but it achieved these positive outcomes at a reduced total exposure to corticosteroids," she said.
  • Using allergy shots to treat some people with allergic asthma. Cloutier said, however, that oral immunotherapy, in which an allergen is placed under the tongue, is not supported by the current evidence.
  • Reducing exposure to indoor asthma triggers for patients who react to specific allergens. The new recommendations are not for people whose asthma is not triggered by allergens, Cloutier said.
  • Using an exhaled nitric oxide test to confirm an asthma diagnosis in some patients when the diagnosis is unclear. The test can also be useful in long-term asthma management, Cloutier said. Elevated levels of nitric oxide can determine whether a patient might need more or different therapy.
  • Using bronchial thermoplasty -- in which heat is used to reduce the muscle surrounding airways -- to treat some adults with persistent asthma.
  • Using long-acting antimuscarinic agents (LAMAs) with inhaled corticosteroids for long-term asthma management. LAMAs are bronchodilators, medicines that help keep airway muscles relaxed.

"If someone is on inhaled corticosteroids and LAMAs already, and their asthma is not controlled, then adding a long-acting muscarinic antagonist offers some benefits," Cloutier said.

While Rizzo welcomed the new guidelines, he expressed concern that access to asthma treatment remains limited for many of those who need it most, including poor Blacks and Hispanics.

He added that the COVID-19 pandemic has caused many people to avoid visiting their doctor's office, and many may not have access to online telemedicine appointments.

"We have to be really attuned to the fact that any improvement in asthma care has to also get rid of the inequities in the access to care that unfortunately exist," Rizzo said.

The new guidelines were published Dec. 3 in the Journal of Allergy and Clinical Immunology.

More information

For more on asthma, visit the U.S. National Heart, Lung, and Blood Institute.

SOURCES: Michelle Cloutier, MD, chair, National Asthma Education Prevention Program Expert Panel Working Group, and professor emerita, pediatrics and medicine, University of Connecticut School of Medicine, Farmington; Albert Rizzo, MD, chief medical officer, American Lung Association, Chicago; Journal of Allergy and Clinical Immunology, Dec. 3, 2020